DARPA Selects Teams to Develop Vaccine Durability Prediction Model
Technologies that can change the way we measure and perceive vaccination-induced immune protection will eliminate the uncertainty and retrospective evaluation ...
Tag: Vaccines
Sabin Vaccine Institute to Advance Ebola Sudan and Marburg Vaccines with New BARDA Funding
Sabin Vaccine Institute receives $35 million from BARDA with potential of up to $214 million for Medical Countermeasure Development against ...
How Are Bivalent COVID Vaccines Stacking Up Against Omicron?
Bivalent COVID vaccines have now been in use for a few months – here’s how they’re stacking up against omicron Vaccines ...
Texas Biomed at Forefront of Sudan ebolavirus Vaccine Development
A Sudan ebolavirus vaccine and antibody therapeutic tested at Texas Biomedical Research Institute have been sent to Uganda as part ...
NIH Begins Clinical Trial of Intradermal Monkeypox Vaccine Delivery to Expand Supply
A clinical trial evaluating alternative strategies for administering the JYNNEOS monkeypox vaccine to increase the number of available doses has ...
Bavarian Nordic to Supply Additional Monkeypox Vaccine to EU Member States
New contract will double the supply of monkeypox vaccines to the European Health Emergency Preparedness and Response Authority (HERA) before ...
New Universal Flu Vaccine Offers Broad Protection Against Influenza A Virus Infections
A new universal flu vaccine constructed with key parts of the influenza virus offers broad cross protection against different strains ...
Adverse Events After Simultaneous COVID-19 mRNA Booster, Flu Vaccination
Are systemic reactions more common after simultaneous administration of COVID-19 mRNA booster and seasonal influenza vaccines than after COVID-19 mRNA ...
US Starts Clinical Trial for mRNA Nipah Virus Vaccine
The experimental Nipah virus vaccine (mRNA-1215) is manufactured by Moderna, Inc. and was developed in collaboration with NIAID’s Vaccine Research ...
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control
New guidance on offering the Imvanex vaccine to men considered to be at higher risk of exposure. A strategy published today by ...
Tonix Pharmaceuticals Opens Advanced Development Center for Vaccine Programs
Internal Manufacturing Capabilities Expected to Support U.S. Pandemic Preparedness Tonix Pharmaceuticals will hold a ribbon-cutting ceremony at the company’s new ...
Resurgent COVID-19, Flu and Other Viruses are Pushing New Zealand’s Health System to the Limit
As Aotearoa New Zealand heads into the colder winter months, the pressures on our health system and staff are growing ...
Politics and Pandemic Fatigue Doom California’s Covid Vaccine Mandates
In January, progressive California Democrats vowed to adopt the toughest Covid vaccine requirements in the country. Their proposals would have ...
Monkeypox Cases Prompt Additional Contracts for Bavarian Nordic Vaccine
Bavarian Nordic's smallpox vaccine is approved for use against monkeypox by the U.S. Food and Drug Administration and Health Canada. ...
Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors
Novavax hitched its wagon to the global coronavirus pandemic. Before most Americans truly grasped the scope of the danger, the ...
NIH Awards $3M Grant to Albany Med for Plague Vaccine Development
Albany Medical College scientists have been awarded a $3 million, five-year federal grant to develop a vaccine that could protect ...
Northwestern University Researchers Develop Nanoparticle Vaccine Platform
Nanoparticle-based COVID-19 vaccine could target future infectious diseases Just one dose of a new nanoparticle-based COVID-19 vaccine was enough to ...
New NIH Study Will Follow Patients That Had Allergic Reaction to mRNA COVID-19 Vaccines
Researchers from the National Institute of Allergy and Infectious Diseases (NIAID) are conducting a clinical trial designed to help understand ...
Newborn Rotavirus Vaccine Set to Save Lives
The award-winning team behind an affordable and effective gastro vaccine is ensuring it will save as many newborn lives as ...
Appili Awarded $10M in New Biodefense Funding for Tularemia Vaccine Candidate
DoD funding aims to advance F. tularensis biodefense vaccine candidate to IND submission Appili Therapeutics Inc. announced this week that ...
